LOW-DOSE ARA-C AS AN ALTERNATIVE THERAPY FOR OLDER PATIENTS WITH AML

被引：0
|
作者：
HEYLL, A [1 ]
AUL, C [1 ]
HEYLL, U [1 ]
FISCHER, JT [1 ]
SCHNEIDER, W [1 ]
机构：
[1] UNIV DUSSELDORF,KLIN A,MED KLIN & POLIKLIN,D-4000 DUSSELDORF,FED REP GER
来源：
BLUT | 1985年 / 51卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：163 / 163
页数：1
相关论文
共 50 条
  • [41] LOW-DOSE ARA-C IN ACUTE LEUKEMIAS - ANALYSIS OF 30 CASES
    YAO, EG
    XU, SR
    DONG, ZR
    LIU, FZ
    CHINESE MEDICAL JOURNAL, 1986, 99 (10) : 832 - 834
  • [42] LOW-DOSE ARA-C IN ACUTE NON-LYMPHOBLASTIC LEUKEMIA
    BUCK, M
    VINCENT, PC
    YOUNG, GAR
    BENSON, WJ
    MEDICAL AND PEDIATRIC ONCOLOGY, 1984, 12 (04): : 295 - 295
  • [43] LOW-DOSE ARA-C(LODAC) IN ACUTE MYELOID-LEUKEMIA
    AMADORI, S
    PETTI, MC
    AVVISATI, G
    SIKOGLOU, N
    MANDELLI, F
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 185 - 185
  • [44] LOW-DOSE ARA-C IN TREATMENT OF OVERT ACUTE-LEUKEMIA
    RUIZARGUELLES, GJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 61 (03) : 584 - 586
  • [45] Dose escalation of ara-C may improve response rates in a subgroup of chronic myeloid leukemia patients with poor response to interferon-α and low-dose ara-C
    Hilbe, W
    Kühr, T
    Apfelbeck, U
    Fridrik, M
    Seewann, H
    Stöger, M
    Linkesch, W
    Pont, J
    Baldinger, C
    Hartner, E
    Bernhart, M
    Geissler, D
    Krieger, O
    Lang, A
    Lin, W
    Ludwig, H
    Duba, C
    Greil, R
    Gastl, G
    Thaler, J
    LEUKEMIA & LYMPHOMA, 2001, 42 (06) : 1283 - 1288
  • [46] Clofarabine and clofarabine plus low-dose cytarabine (ara-C) as induction therapy for patients (pts) ≥ 60 years with newly diagnosed acute myeloid leukemia (AML)
    Faderl, S
    Ravandi, F
    Ferrajoli, A
    Garcia-Manero, G
    Estrov, Z
    Thomas, DA
    O'Brien, S
    Verstovsek, S
    Wierda, W
    Cortes, J
    Giles, FJ
    Kwari, M
    Jarmon, R
    Kantarjian, HM
    BLOOD, 2005, 106 (11) : 786A - 786A
  • [47] A Randomised Assessment of Ganetespib Combined with Low Dose Ara-C Versus Low Dose Ara-C in Older Patients with Acute Myeloid Leukaemia: Results of the LI-1 Trial
    Dennis, Michael
    Hills, Robert K.
    Thomas, Ian
    Gupta, Sunil
    Panoskaltsis, Nicki
    Copland, Mhairi
    Burnett, Alan K.
    Russell, Nigel H.
    BLOOD, 2016, 128 (22)
  • [48] RESULTS OF LOW-DOSE CYTARABINE (ARA-C) AND AGGRESSIVE CHEMOTHERAPY IN PATIENTS WITH ADVANCED MYELODYSPLASTIC SYNDROMES
    AUL, C
    HEYLL, A
    HEYLL, U
    SCHNEIDER, W
    BLUT, 1988, 56 (06): : C19 - C19
  • [49] EFFICACY OF HIGH-DOSE AND INTERMEDIATE-DOSE ARA-C IN PATIENTS WITH SECONDARY AML
    LEITHA, T
    JAGER, U
    SCHWARZINGER, I
    BOGNAR, H
    BETTELHEIM, P
    GEISSLER, K
    HINTERBERGER, W
    KOS, M
    PABINGER, I
    PANZER, S
    NEUMANN, E
    LECHNER, K
    BLUT, 1986, 53 (03): : 141 - 141
  • [50] SEQUENTIAL HIGH-DOSE ARA-C AND ASPARAGINASE IN UNTREATED AML EFFICACY OF A SINGLE DAILY DOSE OF HIGH-DOSE ARA-C
    POWELL, BL
    CRUZ, JM
    LYERLY, ES
    RUSSELL, GB
    WOOD, JH
    STUART, RK
    CHORLEY, HM
    CAPIZZI, RL
    BLOOD, 1993, 82 (10) : A129 - A129
12345